Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
A novel chimeric Rev, Tat, and Nef (Retanef) antigen as a component of an SIV/HIV vaccine
Home
Publications
A novel chimeric Rev, Tat, and Nef (Retanef) antigen as a component of an SIV/HIV vaccine
A novel chimeric Rev, Tat, and Nef (Retanef) antigen as a component of an SIV/HIV vaccine
Author:
ZH
Z Hel
Z Hel
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Publisher website
Google Scholar
1 August 2002
journal article
Published by
Elsevier
in
Vaccine
Vol. 20
(25-26)
,
3171-3186
DOI:
10.1016/s0264-410x(02)00258-x
PMID:
12163269
Abstract
No abstract available
Keywords
HIV VACCINE
TAT
EARLY TIME
TIME POST-INFECTION
ATTRACTIVE TARGETS
REV
NEF
VIRUS TYPE
IMMUNODEFICIENCY VIRUS
HIV
Cited
Cited by 40 articles
Scroll to top